Artificial Intelligence (AI) is changing healthcare worldwide, including in the United States. One special type of AI—agentic AI—needs extra attention from medical office managers, owners, and IT teams. Agentic AI can work on its own, making decisions without constant human help. This ability creates important questions about safety, fairness, and responsibility. While the US is still making its own AI rules, healthcare workers looking at the UK and European Union (EU) laws will find useful ideas for using AI.
This article compares UK and EU rules for agentic AI in healthcare. It shows how these rules handle safety, fairness, and the ability to check how AI works. These are important topics for US healthcare groups planning to use AI tools like Simbo AI’s phone automation and answering systems.
Agentic AI means AI systems that can work by themselves by setting goals and trying to reach them without humans guiding every step. In healthcare, this could be AI helping with patient calls, helping doctors make diagnoses, or managing appointments using voice tech. These systems can learn and get better over time, but this also makes rules tricky.
Agentic AI is different from simple AI that only does tasks it was programmed to do. Because it learns and decides on its own, stronger rules and oversight are needed to keep data safe and patients protected. This is very important for clinics using AI to run phone lines, talk with patients, and make processes easier.
The European Union has created a strict set of rules for AI with the EU AI Act. This is the first big law like it worldwide. The law sees agentic AI in healthcare as a high-risk tool that needs close controls.
The EU AI Act requires all agentic AI used in healthcare to pass strong checks focused on patient safety. Article 14 says humans must keep watch on AI decisions to make sure the AI does not harm care or patient rights. For example, an AI phone system cannot make important decisions alone. Staff must be able to step in.
The General Data Protection Regulation (GDPR) works with the AI Act by forcing clear rules about how AI shows patients what it does. Articles 13 and 14 say AI must explain how it uses patient data and that it works on its own. The EU does not allow “black-box” AI, where no one can understand how decisions are made. Instead, patients must get simple explanations. This fairness lets patients challenge AI decisions per Article 22, which protects them from decisions made only by machines without human review.
Healthcare groups using agentic AI must keep detailed records of AI decisions, technical info, risk checks, and how humans watch AI. The EU wants active management with regular checks to stop AI from doing more than it should. This keeps healthcare groups responsible “data controllers” even when AI works on its own, helping avoid legal trouble.
Dr. Nathalie Moreno, who studied AI rules, says good human oversight in Article 14 is very important because agentic AI learns and acts on its own all the time. This method keeps patients safer without blocking progress.
The UK uses a non-law-based, principles approach for AI rules. It tries to balance safety with new ideas. It uses old laws managed by different agencies.
The UK uses five main ideas: safety, security and strength; openness and clear explanations; fairness; responsibility and governance; and ways to challenge and fix problems. These principles apply to different areas including healthcare. Agencies like the Information Commissioner’s Office (ICO), Financial Conduct Authority (FCA), and Medicines and Healthcare products Regulatory Agency (MHRA) help manage this.
For agentic AI, healthcare managers must show that AI is safe and can be understood in their specific settings. The Department for Science, Innovation and Technology (DSIT) created a central group to coordinate between agencies and keep rules consistent.
The UK wants healthcare groups to do risk checks for their AI tools. Rules will come out in plans by April 2024, guiding how to handle AI risks while supporting new ideas. Clinics must keep humans involved in important AI decisions to keep patients safe and keep responsibility clear.
Fairness is part of UK rules. AI use must follow consumer and equality laws. Transparency means AI should be understandable but UK rules don’t have the same legal power as the EU’s GDPR. Still, the UK government encourages healthcare groups to keep safety and openness for patient confidence and audits.
The UK encourages ongoing checks and records to track how AI works. A group called the AI and Digital Hub, started in 2024, offers healthcare groups advice on following laws before using AI. This helps accountability and prepares managers and IT staff to check AI safety and fairness.
The US does not have full federal AI rules like the EU or UK yet, but looking at their approaches can help US healthcare groups planning to use agentic AI.
AI tools like Simbo AI’s phone answering systems are growing popular. US healthcare providers should get ready for future rules by learning from UK and EU models. Here are some tips:
Agentic AI can run workflows by itself and bring good changes to medical offices, but it also creates rule challenges. For example, Simbo AI’s phone automation can answer patient calls anytime, sort questions, book appointments, and give health info. This helps staff but raises some issues:
Healthcare administrators should treat AI workflow automation as more than just a tool to save time. It is part of their safety, fairness, and audit duties. Lessons from the UK and EU are good guides as US rules develop.
Practice managers, owners, and IT staff in the US will find these ideas helpful for using AI safely and getting ready for possible rules similar to those in the UK and EU.
Agentic AI refers to AI systems capable of autonomous, goal-directed behaviour without direct human intervention. These systems challenge traditional accountability and data protection models due to their independent decision-making and continuous operation, complicating compliance with existing legal frameworks.
The EU AI Act adopts a risk-based approach where agentic AI in healthcare may be classified as high-risk under Annex III, especially if used in biometric identification or medical decision-making. It mandates conformity assessments, risk management, documentation, and human oversight to ensure safety and accountability.
Agentic AI blurs the data controller and processor roles as it may autonomously determine processing purposes and means. Healthcare organisations must maintain dynamic human oversight to remain ‘controllers’ and avoid relinquishing accountability to autonomous AI agents.
Under Articles 13 and 14 GDPR, healthcare AI agents must provide clear, layered, and plain-language notices about data use and AI autonomy. Black-box AI cannot excuse transparency failures, requiring explainability even for emergent or complex decision processes.
Article 22 protects individuals from decisions based solely on automated processing with legal or significant effects. Healthcare AI must ensure meaningful human review, enable contestability, and document safeguards when automated healthcare decisions affect patients’ rights or care.
Agentic AI systems’ continuous learning and real-time data ingestion may conflict with data minimisation and strict purpose limitations. Healthcare providers must define clear usage boundaries, enforce technical constraints, and regularly audit AI functions to prevent purpose creep.
Robust governance includes sector-specific risk assessments, clear responsibility allocation for AI decisions, human-in-the-loop controls, thorough documentation, and ongoing audits to monitor AI behaviours and prevent legal or ethical harms in healthcare contexts.
The UK lacks an overarching AI law, favouring context-specific principles focusing on safety, transparency, fairness, accountability, and contestability. UK regulators provide sector-specific guidance and voluntary cybersecurity codes emphasizing human oversight and auditability for agentic AI in healthcare.
Proactive governance prevents compliance failures by enforcing explainability, accountability, and control over autonomous AI. It involves continuous risk assessment, maintaining AI behaviour traceability, and adapting GDPR frameworks to address agentic AI’s complex, evolving functionalities.
Non-compliance risks include regulatory enforcement actions, reputational damage, and legal uncertainty. Healthcare organisations may face penalties if they fail to demonstrate adequate human oversight, transparency, data protection measures, and accountability for autonomous AI decisions affecting patient data and care.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
